Construction of a prognostic survival model with tumor immune-related genes for breast cancer.

Journal article


Guo, Shuai, Guo, Liang, Li, Jiangyun, Li, Jianguo, Zhang, Qiqi, Zhang, Jing, Boussios, Stergios and Toi, Masakazu 2024. Construction of a prognostic survival model with tumor immune-related genes for breast cancer. Translational Cancer Research. 13 (12), pp. 6919-6935. https://doi.org/10.21037/tcr-24-2137
AuthorsGuo, Shuai, Guo, Liang, Li, Jiangyun, Li, Jianguo, Zhang, Qiqi, Zhang, Jing, Boussios, Stergios and Toi, Masakazu
AbstractNumerous studies have demonstrated that immune cell infiltration is a significant predictor in the prognosis of those with breast cancer. This study aimed to develop a prognostic model for undifferentiated breast cancer using immune-related markers. Differentially expressed genes (DEGs) and prognostic factors were identified from The Cancer Genome Atlas (TCGA) database. Cancer immune-associated genes were filtered using the GeneCards database. Least absolute shrinkage and selection operator (LASSO) and Cox proportional hazards regression were employed to select prognostic indicators. The single-sample gene set enrichment analysis (ssGSEA) algorithm and the CIBERSORT algorithm were used to analyze the correlation of prognostic indicators with immune cells in breast cancer. We identified six tumor immune-related genes, including zic family member 2 ( ), solute carrier family 7 member 5 ( ), forkhead box J1 ( ), C-X-C motif chemokine ligand 9 ( ), tumor necrosis factor receptor superfamily member 18 ( ), and serine protease 2 ( ), for the development of a prognostic model for patients with breast cancer. Notably, the results of the correlation analysis indicated that was associated with antitumor immune cells, including CD8 T cells, cytotoxic cells, M1 macrophages, and activated memory CD4 T cells, and with the enrichment of natural killer (NK) CD56dim cells. Furthermore, exhibited a significant negative association with the tumor-promoting M2 macrophage phenotype. Our study established a six-gene model for predicting breast cancer prognosis. Furthermore, we unexpectedly discovered that is integral to immune infiltration in breast cancer and may serve as a critical biomarker for evaluating immune response and therapeutic efficacy in breast cancer treatment. [Abstract copyright: 2024 AME Publishing Company. All rights reserved.]
KeywordsC-X-C motif chemokine ligand 9 (CXCL9); Immune infiltration; Breast cancer; Prognostic model; Immunomodulators
Year2024
JournalTranslational Cancer Research
Journal citation13 (12), pp. 6919-6935
PublisherAME Publishing
ISSN2219-6803
Digital Object Identifier (DOI)https://doi.org/10.21037/tcr-24-2137
Official URLhttps://tcr.amegroups.org/article/view/94699/html
Publication dates
Online27 Dec 2024
Publication process dates
Accepted18 Dec 2024
Deposited30 Jan 2025
Publisher's version
License
File Access Level
Open
Output statusPublished
Additional information

Publications router.

Permalink -

https://repository.canterbury.ac.uk/item/9q330/construction-of-a-prognostic-survival-model-with-tumor-immune-related-genes-for-breast-cancer

Download files


Publisher's version
tcr-13-12-6919.pdf
License: CC BY-NC-ND 4.0
File access level: Open

  • 4
    total views
  • 0
    total downloads
  • 2
    views this month
  • 0
    downloads this month

Export as

Related outputs

Molecular biomarkers of glial activation and injury in epilepsy
Kalsariya, Reema A, Kavila, Dave, Shorter, Susan, Negi, Deepika, Goodall, Iain C A, Boussios, Stergios and Ovsepian, Saak V 2025. Molecular biomarkers of glial activation and injury in epilepsy. Drug Discovery Today. 30 (2), p. 104289. https://doi.org/10.1016/j.drudis.2025.104289
AI-guided cancer therapy for patients with coexisting migraines
Olawade, D., Teke, J., Adeleye, K., Egbon, E., Weerasinghe, K., Ovespian, S. and Boussios, S. 2024. AI-guided cancer therapy for patients with coexisting migraines. Cancers. 16 (21), p. 3690. https://doi.org/10.3390/cancers16213690
An orthogonal approach for analysis of underivatized steroid hormones using ultrahigh performance supercritical fluid chromatography-mass spectrometry (UHPSFC-MS).
Devo, Perry, Cretu, Victoria, Radhakrishnan, Harsha, Hamilton-Pink, Darren, Boussios, Stergios and Ovsepian, S. 2024. An orthogonal approach for analysis of underivatized steroid hormones using ultrahigh performance supercritical fluid chromatography-mass spectrometry (UHPSFC-MS). Journal of Neural Transmission. https://doi.org/10.1007/s00702-024-02862-3
Bilateral dermoid ovarian cysts in a young woman - A case report and literature review
Pinnamaneni, Sravya, Sayani, Sunayana, Chilakuluri, Premsai and Boussios, Stergios 2024. Bilateral dermoid ovarian cysts in a young woman - A case report and literature review. Cancer diagnosis & prognosis. 4 (6), pp. 819-824. https://doi.org/10.21873/cdp.10402
Early adoption of innovation in HPV prevention strategies: closing the gap in cervical cancer.
Mahajan, Ishika, Kadam, Amogh, McCann, Lucy, Ghose, Aruni, Wakeham, Katie, Dhillon, Navjot Singh, Stanway, Susannah, Boussios, Stergios, Banerjee, Soirindhri, Priyadarshini, Ashwini, Sirohi, Bhawna, Torode, Julie S and Mitra, Swarupa 2024. Early adoption of innovation in HPV prevention strategies: closing the gap in cervical cancer. Ecancermedicalscience. 18, p. 1762. https://doi.org/10.3332/ecancer.2024.1762
Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape
Hetvi Ganatra, Joecelyn Kirani Tan, Ana Simmons, Carola Maria Bigogno, Vatsala Khurana, Aruni Ghose, Adheesh Ghosh, Ishika Mahajan, Boussios, S., Akash Maniam and Olubukola Ayodele 2024. Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape. Breast Cancer.
Paediatric anatomical models in radiotherapy applications
Apte, V, Ghose, A, Linares, C A, Adeleke, S, Papadopoulos, V, Rassy, E and Boussios, S 2024. Paediatric anatomical models in radiotherapy applications. Clinical Oncology (Royal College of Radiologists (Great Britain)). https://doi.org/10.1016/j.clon.2024.06.051
Large language models in oncology: Revolution or cause for concern?
Caglayan, Aydin, Slusarczyk, Wojciech, Rabbani, Rukhshana Dina, Ghose, Aruni, Papadopoulos, Vasileios and Boussios, Stergios 2024. Large language models in oncology: Revolution or cause for concern? Current Oncology. 31 (4). https://doi.org/10.3390/curroncol31040137
Antibody drug conjugates in urological cancers: A review of the current landscape
Ghose, Aruni, Lapitan, Patricia, Apte, Vedika, Ghosh, Adheesh, Kandala, Abhinav, Basu, Sreejana, Parkes, Jo, Shinde, Sayali D, Boussios, Stergios, Sharma, Anand, Das, Prantik, Vasdev, Nikhil, Rebuzzi, Sara E, Ürün, Yüksel, Kanesvaran, Ravindran, Maniam, Akash and Banna, Giuseppe L 2024. Antibody drug conjugates in urological cancers: A review of the current landscape. Current Oncology Reports. https://doi.org/10.1007/s11912-024-01524-7
The application of radiomics and AI to molecular imaging for prostate cancer
Tapper, William, Carneiro, G., Mikropoulos, C., Thomas, Spencer A., Evans, P. and Boussios, S. 2024. The application of radiomics and AI to molecular imaging for prostate cancer. Journal of Personalized Medicine. 14 (3), p. 287. https://doi.org/10.3390/jpm14030287
Immunotherapy combined with standard therapies in head and neck squamous cell carcinoma - a meta-analysis
Eden, Daisy, Ghose, Aruni, Moschetta, Michele, Pérez-Fidalgo, José Alejandro, Rassy, Elie and Boussios, Stergios 2024. Immunotherapy combined with standard therapies in head and neck squamous cell carcinoma - a meta-analysis. Anticancer Research. 44 (3), pp. 861-878. https://doi.org/10.21873/anticanres.16880
Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4
Ghose, A., McCann, Lucy, Makker, S., Mukherjee, Uma, Gullapalli, Sri Vidya Niharika, Erekkath, Jayaraj, Shih, Stephanie, Mahajan, Ishika, Sanchez, Elisabet, Uccello, Mario, Moschetta, Michele, Adeleke, S. and Boussios, Stergios 2024. Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4. Therapeutic Advances in Medical Oncology. 16, p. 1758835924123225. https://doi.org/10.1177/17588359241233225
A rare case of metaplastic breast carcinoma from India: Towards precision oncology (Case Report)
Soirindhri Banerjee, Ishika Mahajan, Aruni Ghose, Stergios Boussios and Shivam Chakraborty 2024. A rare case of metaplastic breast carcinoma from India: Towards precision oncology (Case Report). Cancer Reports. https://doi.org/10.1002/cnr2.1997
Stage 3 N2 lung cancer: A multidisciplinary therapeutic conundrum
Lily Carter, Vedika Apte, Arushi Shukla, Aruni Ghose, Raj Mamidi, Alexandra Petohazi, Shania Makker, Soirindhri Banerjee, Stergios Boussios and Giuseppe L. Banna 2024. Stage 3 N2 lung cancer: A multidisciplinary therapeutic conundrum. Current Oncology Reports. 26, pp. 65-79.
Frontiers of molecular biology of cancer
Boussios, S., Sanchez, E. and Sheriff, M. 2023. Frontiers of molecular biology of cancer. International Journal of Molecular Sciences.
Frontiers of ovarian carcinosarcoma
Ismail, A., Choi, S. and Boussios, S. 2023. Frontiers of ovarian carcinosarcoma. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-023-01138-4
Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness
Ping Huang, Huachao Li, Liping Ren, Haimei Xie, Liushan Chen, Yuqi Liang, Yuyu Hu, Heloisa Sobreiro Selistre-de-Araujo, Stergios Boussios, Sachin R. Jhawar, Rutao Cui, Qian Zuo and Qianjun Chen 2023. Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness. Translational Cancer Research. 12 (12).
Hallmarks of the tumour microenvironment of gliomas and its interaction with emerging immunotherapy modalities
Christian A. Linares, Anjana Varghese, Aruni Ghose, Sayali D. Shinde, Sola Adeleke, Elisabet Sanchez, Matin Sheriff, Cyrus Chargari, Elie Rassy and Stergios Boussios 2023. Hallmarks of the tumour microenvironment of gliomas and its interaction with emerging immunotherapy modalities. International Journal of Molecular Sciences. 24 (17), p. 13215. https://doi.org/10.3390/ijms241713215
Prognostic factors in patients with metastatic spinal cord compression secondary to lung cancer—A retrospective UK single-centre study
Anna Vassiliou, Temidayo Osunronbi, Synthia Enyioma, Gerardo Rago, Afroditi Karathanasi, Aruni Ghose, Matin Sheriff, Christos Mikropoulos, Elisabet Sanchez, Michele Moschetta, Cyrus Chargari, Elie Rassy and Stergios Boussios 2023. Prognostic factors in patients with metastatic spinal cord compression secondary to lung cancer—A retrospective UK single-centre study. Cancers. 15 (18), p. 4432. https://doi.org/10.3390/cancers15184432
Exosomes in the diagnosis and treatment of renal cell cancer
Boussios, S., Devo, P., Goodall, Iain C A, Sirlantzis, Konstantinos, Ghose, A., Shinde, Sayali D, Papadopoulos, Vasileios, Sanchez, Elisabet, Rassy, E. and Ovsepian, Saak V 2023. Exosomes in the diagnosis and treatment of renal cell cancer. International Journal of Molecular Sciences. 24 (18), p. 14356. https://doi.org/10.3390/ijms241814356
Immunotherapy for advanced urothelial carcinoma (UC): rational and current evidence
Mario Uccello, Sola Adeleke, Michele Moschetta, Aruni Ghose and Stergios Boussios 2023. Immunotherapy for advanced urothelial carcinoma (UC): rational and current evidence. Annals of Palliative Medicine. https://doi.org/10.21037/apm-22-1350
Clinical challenges in the management of malignant ovarian germ cell tumours
Iqra Saani, Nitish Raj, Raja Sood, Shahbaz Ansari, Haider Abbas Mandviwala, Elisabet Sanchez and Stergios Boussios 2023. Clinical challenges in the management of malignant ovarian germ cell tumours. International Journal of Environmental Research and Public Health. 20 (12), p. 6089.
Impact of COVID-19 on cancer services and patients' outcomes: a retrospective single-center study
Baijaeek Sain, Arnab Gupta, Aruni Ghose, Sudip Halder, Samir Bhattacharya, Radha Raman Mondal, Subhamoy Paul, Chandrakanth Are and Stergios Boussios 2023. Impact of COVID-19 on cancer services and patients' outcomes: a retrospective single-center study. Annals of Translational Medicine. 11 (9). https://doi.org/10.21037/atm-22-5876
Advances in adoptive T-cell therapy for metastatic melanoma
Das, Aparimita, Ghose, Aruni, Naicker, Kevin, Sanchez, Elisabet, Chargari, Cyrus, Rassy, Elie and Boussios, S. 2023. Advances in adoptive T-cell therapy for metastatic melanoma. Current Research in Translational Medicine. 71 (3), p. 103404. https://doi.org/10.1016/j.retram.2023.103404
Prostate cancer - what about oligometastatic disease and stereotactic ablative radiotherapy? - a narrative review
Boussios, S., Saxby, H. and Mikropoulos, C. 2023. Prostate cancer - what about oligometastatic disease and stereotactic ablative radiotherapy? - a narrative review. Annals of Palliative Medicine. 12 (3). https://doi.org/10.21037/apm-22-828
HPV and cervical cancer: A review of epidemiology and screening uptake in the UK
Sunyoung Choi, Ayden Ismail, George Pappas-Gogos and Stergios Boussios 2023. HPV and cervical cancer: A review of epidemiology and screening uptake in the UK. Pathogens (Basel, Switzerland). 12 (2). https://doi.org/10.3390/pathogens12020298
Constrictive pericarditis–a cloak camouflaging lymphoma
Delanthabettu Venugopala, Nikhil Victor Dsouza, Vishak Acharya, Maneesh Rai, Chaithra Gowthuvalli Venkataramana and Stergios Boussios 2022. Constrictive pericarditis–a cloak camouflaging lymphoma. Hematology Reports. 15 (1), pp. 166-171. https://doi.org/10.3390/hematolrep15010017